Urinary Excretion of Platinum, Arsenic and Selenium of Cancer Patients Treated with Platinum-Based Drugs
Published: Thursday, May 03, 2012 Last Updated: Thursday, May 03, 2012
Arsenic exposure increases the risk of non-cancerous and cancerous diseases. This study characterised the short-term urinary excretion amounts of arsenic, selenium and platinum in 24-h urine samples from patients with lung cancer and those with other types of cancer.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.